2016 Archived Content

Distinguished Faculty:


Immunogenicity Assessment & Clinical Relevance | Immunogenicity Prediction & Control
Optimizing Bioassays for Biologics

Immunogenicity Assessment & Clinical Relevance

Paul Chamberlain, NDA Advisory Board

Shan Chung, Ph.D., Senior Scientist, BioAnalytical Sciences, Genentech, Inc.

Kathleen A. Clouse, Ph.D., Director, Division of Biotechnology Review and Research 1, OBP/OPQ/CDER/FDA

Kimberly Florence, MS, Investigator, Immunogenicity and Clinical Immunology, GlaxoSmithKline

Boris Gorovits, Ph.D., Senior Director, PDM, Pfizer, Inc.

John Kamerud, Ph.D., Scientific Director, Eurofins Pharma Bioanalytical Services

Mark Ma, Ph.D., Senior Director, Bioanalytical Development, Alexion Pharmaceuticals, Inc.

Jim McNally, Ph.D., Associate Director and Immunogenicity Expert, Global Early Development, Quantitative Pharmacology & Drug Disposition, EMD Serono

Andrew C. Melton, Ph.D., Scientist II, Bioanalytical R&D, BioMarin Pharmaceutical, Inc.

Samuel Pine, Ph.D., Principal Scientist, Immunology, Allergan

Joao Pedras-Vasconcelos, Ph.D., Biotech Quality and Immunogenicity Reviewer, Office of Biotechnology Products, CDER-FDA

Melissa R. Snyder, Ph.D., Laboratory Director, Antibody Immunology Laboratory, Pathology and Laboratory Medicine, Mayo Clinic

Niels Vande Casteele, Pharm.D., Ph.D., Postdoctoral Fellow, Gastroenterology, University of California, San Diego

Karin Nana Weldingh, Ph.D., Principal Scientist, Immunogenicity Assessment, Novo Nordisk

Weifeng Xu, Ph.D., Senior Research Investigator, Bioanalytical Science-Biologics, BMS

Jad Zoghbi, MSc, Senior Scientist, Biomarkers and Clinical Bioanalyses, Sanofi

Immunogenicity Prediction & Control

Gary Bembridge, Ph.D., Director, Scientific Affairs, Abzena

Michael Brehm, Ph.D., Associate Professor, Molecular Medicine, University Massachusetts Medical School

Sally Fischer, Ph.D., Principal Scientist & Group Leader, Assay Development & Technology (ADT), Genentech, Inc.

Will Hallett, Ph.D., Product Quality and Immunogenicity Reviewer, CDER/FDA

Tim Hickling, Ph.D., Immunogenicity Sciences Lead, Biomedicine Design, Pfizer, Inc.

Vibha Jawa, Ph.D., Principal Scientist, Clinical Immunology, Amgen, Inc.

Kei Kishimoto, Ph.D., CSO, Selecta Biosciences

Emilee Knowlton, D. Phil., Immunology Sales Specialist, ProImmune

Kasper Lamberth, Ph.D., Manager, Immunogenicity Prediction & Tolerance, Novo Nordisk A/S

Ronit Mazor, Ph.D., Post-Doctoral Fellow, Molecular Biology, National Cancer Institute, National Institutes of Health

J. Joseph (Jos) Melenhorst, Ph.D., Director, Product Development & Correlative Sciences, Center for Cellular Immunotherapies, University of Pennsylvania

Ira Pastan, M.D., Co-Chief, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health

Harald Petry, Ph.D., Chief Scientific Officer, Research and Development, uniQure

Valerie Quarmby, Ph.D., Staff Scientist, BioAnalytical Sciences, Genentech, Inc.

Susan Richards, Ph.D., Presidential Scientific Fellow, Translational Medicine Early Development, Sanofi R&D

Zuben Sauna, Ph.D., Principal Investigator, Division of Hematology Research and Review, FDA/CBER

Ethan Shevach, M.D., Senior Investigator, Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Optimizing Bioassays for Biologics

Sebastien Boridy, BSc, Ph.D., Research Scientist, Immunology, Charles River

Peter Day, Ph.D., Scientist, Genentech

Jamil Hantash, MSc, MBA, Vice President, Pharmaceutical Services, Intertek Pharmaceutical Services

Jenny Hu, Scientist, PKDM, Amgen Inc.

Martin Kane, Managing Data Scientist, Statistical and Data Sciences, Exponent

David Lansky, Ph.D., President, Precision Bioassay, Inc.

Thomas Little, Ph.D., President, Bioassay Sciences, Thomas A. Little Consulting

Ravish Patel, Ph.D., Scientist, Analytical Development Lab, EPR Centre for Cancer Research & Bioinformatics Pvt. Ltd. (A Vitane Group company)

Sofie Pattijn, CTO, ImmuneXperts

Alpana Prasad, Ph.D., Product Manager, Marketing, DiscoverX Corporation

Matthew Roberts, Ph.D., Investigator, GlaxoSmithKline

Melody Sauerborn, Ph.D., Head, Research and Development, Mymetics BV

Perceval Sondag, Senior Statistician, Non-Clinical Statistics, Arlenda

Michael Tovey, Ph.D., INSERM Director, Research, Laboratory of Biotechnology & Applied Pharmacology, Ecole Normale Supérieure de Cachan


Register

CONFERENCE PROGRAMS